The total value of the polyethylene glycol market was about USD 4,534.8 million in 2021, and it will grow at a CAGR of 4.8% in the years to come for reaching a value of USD 6,909.6 million by 2030, as per a report by P&S Intelligence.
The PEG 400 category had the largest share, and it would grow at a momentous growth rate, of over 5%, in the years to come, on the basis on grade. This will mostly because of the fact that PEG 400 is a low-molecular-weight grade with low toxicity.
Moreover, it is hydrophilic, which lets for its use in the manufacturing of drugs for increasing the bioavailability and solubility of weakly water-soluble drugs. It is likewise put to use in ophthalmic solutions for relief from the annoyance, burning, and/or uneasiness that one experiences after the drying of the eyes.
The opaque liquid had the largest share in the industry in the recent past, on the basis of form. This was mostly because of the high use of this form of polyethylene glycol in the pharma sector as a release agent and excipient for capsules.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/polyethylene-glycol-peg-market/report-sample
Furthermore, the use of polyethylene glycol instead of MEG in the pharma industry will impact the industry positively.
The pharma industry’s growth in developing economies, such as India, China, and Brazil, as well as the growing spending on technological progressions, will drive the polyethylene glycol market. PEG is put to use as an inactive ingredient in the pharma industry, such as a solvent, plasticizer, surfactant, ointment, and suppository base for capsules and tablets.
The outburst of novel ailments and increasing obesity cases, cardiovascular diseases, skeletal problems, and hypertension contribute to the growing healthcare spending all over the world, which, in order, will power the requirement for this chemical.
Comments